195 related articles for article (PubMed ID: 6703673)
1. Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae.
Schuster FL; Mandel N
Antimicrob Agents Chemother; 1984 Jan; 25(1):109-12. PubMed ID: 6703673
[TBL] [Abstract][Full Text] [Related]
2. Amoebicidal effect of chlorine dioxide gas against pathogenic Naegleria fowleri and Acanthamoeba polyphaga.
Sohn HJ; Park AY; Lee JH; Yun KH; Song KJ; Kim JH; Shin HJ
Parasitol Res; 2024 Apr; 123(4):192. PubMed ID: 38652173
[TBL] [Abstract][Full Text] [Related]
3. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
4. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
5. The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Alawfi BS; Khan NA
Parasitol Res; 2023 Nov; 122(11):2539-2548. PubMed ID: 37665414
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
7. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
Peroutka-Bigus N; Bellaire BH
J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
[TBL] [Abstract][Full Text] [Related]
8. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
[TBL] [Abstract][Full Text] [Related]
9. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
10. Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.
Taravaud A; Fechtali-Moute Z; Loiseau PM; Pomel S
Clin Transl Sci; 2021 May; 14(3):791-805. PubMed ID: 33650319
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
Baig AM
Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
[TBL] [Abstract][Full Text] [Related]
12. Antiamoebic activities of flavonoids against pathogenic free-living amoebae, Naegleria fowleri and Acanthamoeba species.
Lê HG; Võ TC; Kang JM; Nguyễn TH; Hwang BS; Oh YT; Na BK
Parasites Hosts Dis; 2023 Nov; 61(4):449-454. PubMed ID: 38043540
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.
Mattana A; Biancu G; Alberti L; Accardo A; Delogu G; Fiori PL; Cappuccinelli P
Antimicrob Agents Chemother; 2004 Dec; 48(12):4520-7. PubMed ID: 15561820
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic free-living amoebae: epidemiology and clinical review.
Trabelsi H; Dendana F; Sellami A; Sellami H; Cheikhrouhou F; Neji S; Makni F; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):399-405. PubMed ID: 22520593
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
Visvesvara GS; Moura H; Schuster FL
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
[TBL] [Abstract][Full Text] [Related]
16. Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
Akbar N; Hussain K; Khalid M; Siddiqui R; Shah MR; Khan NA
J Appl Microbiol; 2023 Apr; 134(4):. PubMed ID: 37024269
[TBL] [Abstract][Full Text] [Related]
17. Effect of thermal additions on the density and distribution of thermophilic amoebae and pathogenic Naegleria fowleri in a newly created cooling lake.
Tyndall RL; Ironside KS; Metler PL; Tan EL; Hazen TC; Fliermans CB
Appl Environ Microbiol; 1989 Mar; 55(3):722-32. PubMed ID: 2930172
[TBL] [Abstract][Full Text] [Related]
18. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae".
Baig AM
Infect Disord Drug Targets; 2020; 20(2):115-121. PubMed ID: 30961516
[TBL] [Abstract][Full Text] [Related]
19. Brain-eating Amoebae Infection: Challenges and Opportunities in Chemotherapy.
Mungroo MR; Anwar A; Khan NA; Siddiqui R
Mini Rev Med Chem; 2019; 19(12):980-987. PubMed ID: 30868950
[TBL] [Abstract][Full Text] [Related]
20. Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of
Shi D; Chahal KK; Oto P; Nothias LF; Debnath A; McKerrow JH; Podust LM; Abagyan R
ACS Infect Dis; 2019 Dec; 5(12):2029-2038. PubMed ID: 31583882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
